FIELD: pharmacology.
SUBSTANCE: invention refers to the application of a compound of formula R1-COOH (I), where R1 is an alkyl group with a main chain of 7-11 carbon atoms, possibly branched in any position of the carbon atom in the main chain, where branching is a side C1-6 alkyl group. The alkyl group of the main chain and/or the side alkyl groups optionally contain one or more heteroatoms. The specified compound is selected from 4-ethyl octanoic acid, 2-butyl octanoic acid, 4-methyl nonanoic acid and 3-methyl undecanoic acid or its pharmaceutically acceptable salt, amide or ester, for treatment or prevention of disease or biomedical state, selected from disorders associated with cramps.
EFFECT: increased efficiency of the composition and treatment method.
2 cl, 9 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC USE OF COMPOUNDS | 2011 |
|
RU2806629C2 |
| ESTERS OF BETA-HYDROXYBUTYRATE AND BUTANEDIOL FORMED BY MEDIUM-CHAIN FATTY ACIDS AND COMPOSITIONS AND METHODS BASED ON THEM | 2017 |
|
RU2761829C2 |
| USE OF DERIVATIVES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID AS CHEMOPROPHYLACTIC AND CHEMOTHERAPEUTIC AGENTS INCOLON CANCER | 1995 |
|
RU2161487C2 |
| COMBINATION CONTAINING DECANOIC ACID FOR TREATMENT OF EPILEPSY | 2018 |
|
RU2779202C2 |
| COMPOSITION FOR USE IN THE TREATMENT OF EPILEPSY | 2018 |
|
RU2793246C2 |
| COMPOUNDS OF BENZOXAZEPINOXAZOLIDINONES AND METHODS OF USING | 2016 |
|
RU2730529C2 |
| COMBINATIONS CONTAINING ALPHA-2-DELTA LIGANDS AND SEROTONIN/NORADRENALINE REUPTAKE INHIBITORS | 2004 |
|
RU2320369C2 |
| INHIBITORY SOLUTION AND METHOD OF SUPPRESSION OF PAIN, INFLAMMATION OR SPASM | 1995 |
|
RU2180852C2 |
| APPLICATION OF 2-HYDROXYDERIVATIVES OF POLYUNSATURATED FATTY ACIDS AS MEDICATIONS | 2010 |
|
RU2513995C2 |
| METHODS AND COMPOSITIONS WITH APPLICATION OF IMMUNOMODELLING COMPOUNDS IN COMBINED TREATMENT | 2007 |
|
RU2426542C2 |
